Results 261 to 270 of about 6,007,608 (352)
Genetics of Response to ECT, TMS, Ketamine and Esketamine
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.ABSTRACT Treatment‐resistant mood disorders are often managed with intensive interventions that include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), ketamine, and esketamine, but the role of genetics in clinical response to those interventions is yet to be clearly determined.
Clio E. Franklin +18 more
wiley +1 more source
Assessment of Patient Satisfaction with Pharmaceutical Community Services in R. Macedonia
, 2011 Zoran Sterjev +5 more
openalex +1 more source
Research in Social and Administrative Pharmacy, 2020 Si-qian Zheng +5 more
semanticscholar +1 more source
American Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.ABSTRACT Rare diseases impact approximately 1 in 10 people worldwide, and yet, less than 5% of all rare diseases currently have an approved treatment option available. This is due to many challenges unique to rare diseases, including small, diverse patient populations, the cost of drug development that is not proportionate to the number of patients who
Caleb P. Bupp +7 more
wiley +1 more source
Diglycerides of Natural Phenols and Organic Acids for Enhanced Biological Activities
Asian Journal of Organic Chemistry, EarlyView.Diglycerides of natural organic acids and phenols were synthesized regio‐selectively. Diglycerides are structurally similar to cell membranes and are expected to exhibit cell affinity and permeability. The flexible glycerol linkers allow the diglycerides to exhibit not only the physiological activities of each constituent organic acid but also the ...
Jisu Hong +10 more
wiley +1 more source
Cultivating of Service-Oriented Pharmaceutical Talents in China
, 2013 Rong Xu, Shao Ming-li
openalex +2 more sources
APPLICATION OF THE ASSESSMENT OF CONSUMER SATISFACTION WITH PHARMACEUTICAL SERVICES: A REVIEW
, 2014 Brígida Dias Fernandes +3 more
openalex +2 more sources
Premenopausal bilateral oophorectomy and Alzheimer's disease imaging biomarkers later in life
Alzheimer's &Dementia, EarlyView.Abstract INTRODUCTION Premenopausal bilateral oophorectomy (PBO) before the age of 46 years is associated with an increased risk of dementia. We investigated the long‐term effects of PBO performed before age 50 years on amyloid beta (Aβ), tau, and neurodegeneration imaging biomarkers of Alzheimer's disease (AD).
Kejal Kantarci +13 more
wiley +1 more source